0755-82557621 sales@chiplinkstech.com Mon–Fri 09:00–18:00 (UTC+8)
Precision motion control · Components and solutions

Trinamic Medical Success Story: TMCM6110

Malaria is the world's deadliest infectious disease, widely spread in tropical regions of Asia, Africa, and South America. If diagnosed promptly and combined with advanced treatment, it can be effectively cured. To determine the presence, species, and number of malaria parasites, trained technicians must examine blood samples under a microscope to complete the standard malaria testing procedure. […]

2020-12-14 Frequently Asked Questions
Trinamic医疗成功的事例之TMCM6110

Malaria is the world's deadliest infectious disease, widely spread in tropical regions of Asia, Africa, and South America. If malaria is diagnosed promptly and combined with advanced treatment, patients can recover effectively. Determining the presence, species, and count of malaria requires trained technicians to examine blood samples under a microscope to complete the standard malaria testing procedure. India alone performs more than 175 million malaria tests each year.

Sight Diagnostics is an emerging company based in Israel that has developed a very special diagnostic technology, representing a significant advance over detecting malaria with a human microscope. Using image processing and advanced algorithms, Sight Diagnostics' Parasight Platform can identify, enumerate, and classify abnormal malaria blood samples faster and more consistently than human technicians.

Stepper Motor DriversExpertsTrinamic Motor Control was selected by Sight Diagnostics as the primary supplier for its Parasight platform. The "Parasight" platform is an automated diagnostic system about the size of a coffee machine; it can receive 30 individual blood samples on a loader and inspect them through a digital imaging lens. The current Parasight platform design uses four stepper motors:

1. Two stepper motors move the sample slide through a predefined X/Y search grid to complete a comprehensive analysis of the blood sample under test.

2. The third stepper motor controls the Z-axis image focusing mechanism.

3. The fourth stepper motor manages the infeed conveyor for multiple sample trays.

Sight Diagnostics, a resource-limited startup, chose Trinamic's TMCM6110 single-axis stepper driver module for the Parasight platform, saving considerable energy. The low-power and compactTMCThe M6110 board is well suited to systems with 3 to 6 motor axes and, combined with our TMC260 stepper motor driver and TMC429 stepper motion control IC, provides precise, individual control of each axis. The unit is preconfigured to meet the performance requirements of NEMA17 stepper motors. The onboard ARM microcontroller coordinates the operation of each motor and communicates with the host processor via RS-485, USB, or CAN.

With precise control, the TMCM-6110 provides 256 microsteps per full step, meeting the Parasight platform's requirements. Using TMC's more intuitive and leading development tools, Sight Diagnostics was able to quickly implement and optimize its motion control application and focus its strategic design core on enhancing its unique IP (including leading imaging technology and algorithms).

The driver module also meets Sight Diagnostics' strict requirements for high reliability, low maintenance cost, and high cost-effectiveness. The Parasight platform is designed to operate in tropical environments up to 37°C, and the device can be used for operation even in remote rural areas far from repair facilities and service technicians.

Sight Diagnostics CEO Yossi Pollak explained: 'When selecting a motion control supplier for the Parasight Platform, we had two primary goals. Because of limited time and the engineers' investment in this non-core part of our product, we needed a motion control module that was absolutely intuitive and simple in design. After implementing our motion control algorithms, we needed cost-competitive components that would continue to be used under adverse conditions and provide the necessary reliability for medical applications.'

Today, the Parasight platform is undergoing extensive field and clinical trials. Its accuracy is above 99%, and it is 50 times faster than trained operators. The company hopes to successfully deploy diagnostic devices globally in 2015. Currently, Sight Diagnostics is also developing other diagnostic devices,TrinamicProvided substantial assistance to its company's technical support.

← Back to News